Omaha, NE, United States of America

Evan Scott Luxon

This inventor holds 26 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Wearable Medical Devices. Top assignees: Theranova, LLC, Bone Health Technologies, Inc., Potrero Medical, Inc.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evan Scott Luxon. Retrieved from https://idiyas.com/inventor/evan-scott-luxon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26 

% Patents Active = 84.6

 

 

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 123(Granted Patents)


Location History:

  • San Francisco, CA (US) (2016 - 2021)
  • Lincoln, NE (US) (2018 - 2022)
  • Omaha, NE (US) (2015 - 2024)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Osteopenia
Osteoporosis
Wearable Apparatus
Bodily Fluids
Gastric Residual Volume
Physiologic Parameters
Bone Growth
Hydrophilic Layer
Analyte Sensing
Chest Drainage
Diabetes Treatment
Bone Screw Anchor
26 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Evan Scott Luxon

Introduction

Evan Scott Luxon, based in Omaha, NE, is a notable inventor with a robust portfolio of 23 patented innovations. His work primarily focuses on advancements in health technology, targeting critical areas such as bone health and patient care. Luxon's inventions not only demonstrate his ingenuity but also his commitment to improving medical outcomes.

Latest Patents

Among his latest contributions is a patent for a wearable apparatus designed for the treatment or prevention of osteopenia and osteoporosis. This innovative device employs mechanical vibrations to stimulate bone growth, enhance bone mineral density, and inhibit fat cell formation. The wearable apparatus includes vibrating elements that are strategically positioned on the body to deliver therapeutic effects to the hip, femur, and spine. Additionally, this invention incorporates accelerometers to monitor and adjust the position and efficacy of the vibrating elements for optimal results.

Another significant patent developed by Luxon pertains to devices and methods for measuring gastric residual volume (GRV). This invention involves deploying a GRV indicator into the stomach to sense changes in physical characteristics, thus allowing healthcare providers to accurately determine GRV. This information is crucial for adjusting a patient’s feeding regimen to ensure adequate nutrition while minimizing complications.

Career Highlights

Evan Scott Luxon has made significant strides in the biotechnology sector, contributing his expertise to companies such as Theranova, LLC and Bone Health Technologies, Inc. His role in these organizations reflects his dedication to pioneering advancements that enhance patient care through innovative medical devices.

Collaborations

Throughout his career, Luxon has collaborated with notable professionals in the field, including Daniel Rogers Burnett and Marcie Hamilton. These partnerships have allowed him to combine talents and insights, resulting in groundbreaking innovations and furthering the impact of his work on healthcare.

Conclusion

Evan Scott Luxon exemplifies the spirit of innovation through his extensive portfolio of patents and collaborative efforts in the health technology sector. His contributions represent a significant step forward in medical device technology, aimed at improving the quality of life for patients facing challenges such as osteoporosis and other health concerns. As he continues to develop new solutions, Luxon remains a key figure in the realm of healthcare innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…